ProShare Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $446K | Sell |
18,010
-4,489
| -20% | -$107K | ﹤0.01% | 1132 |
|
|
2025
Q4 | $525K | Buy |
22,499
+702
| +3% | +$15.6K | ﹤0.01% | 1107 |
|
|
2025
Q3 | $429K | Sell |
21,797
-4,024
| -16% | -$82.8K | ﹤0.01% | 1194 |
|
|
2025
Q2 | $560K | Sell |
25,821
-772
| -3% | -$18.2K | ﹤0.01% | 1061 |
|
|
2025
Q1 | $645K | Sell |
26,593
-7,106
| -21% | -$160K | ﹤0.01% | 973 |
|
|
2024
Q4 | $703K | Buy |
33,699
+10,379
| +45% | +$223K | ﹤0.01% | 1077 |
|
|
2024
Q3 | $464K | Buy |
23,320
+6,158
| +36% | +$114K | ﹤0.01% | 1180 |
|
|
2024
Q2 | $266K | Sell |
17,162
-5,295
| -24% | -$82.4K | ﹤0.01% | 1370 |
|
|
2024
Q1 | $358K | Buy |
22,457
+3,614
| +19% | +$54.5K | ﹤0.01% | 1303 |
|
|
2023
Q4 | $317K | Buy |
18,843
+3,564
| +23% | +$48.7K | ﹤0.01% | 1335 |
|
|
2023
Q3 | $179K | Buy |
15,279
+192
| +1% | +$2.57K | ﹤0.01% | 1503 |
|
|
2023
Q2 | $203K | Buy |
15,087
+1,056
| +8% | +$15.2K | ﹤0.01% | 1532 |
|
|
2023
Q1 | $233K | Sell |
14,031
-1,243
| -8% | -$20.5K | ﹤0.01% | 1363 |
|
|
2022
Q4 | $284K | Buy |
15,274
+2,027
| +15% | +$31.2K | ﹤0.01% | 1271 |
|
|
2022
Q3 | $169K | Buy |
13,247
+2,484
| +23% | +$29.4K | ﹤0.01% | 1443 |
|
|
2022
Q2 | $75K | Sell |
10,763
-7,445
| -41% | -$54.6K | ﹤0.01% | 1655 |
|
|
2022
Q1 | $151K | Sell |
18,208
-3,008
| -14% | -$21.3K | ﹤0.01% | 1951 |
|
|
2021
Q4 | $143K | Buy |
21,216
+8,774
| +71% | +$57.7K | ﹤0.01% | 2137 |
|
|
2021
Q3 | $66K | Sell |
12,442
-12,748
| -51% | -$69.7K | ﹤0.01% | 1953 |
|
|
2021
Q2 | $145K | Sell |
25,190
-743
| -3% | -$3.83K | ﹤0.01% | 2223 |
|
|
2021
Q1 | $120K | Buy |
25,933
+4,427
| +21% | +$17.6K | ﹤0.01% | 2142 |
|
|
2020
Q4 | $72K | Buy |
21,506
+9,606
| +81% | +$32.3K | ﹤0.01% | 2022 |
|
|
2020
Q3 | $35K | Sell |
11,900
-1,291
| -10% | -$5.05K | ﹤0.01% | 1612 |
|
|
2020
Q2 | $61K | Buy |
+13,191
| New | +$59.3K | ﹤0.01% | 1622 |
|
|
2020
Q1 | – | Sell |
-13,078
| Closed | -$49K | – | 1254 |
|
|
2019
Q4 | $49K | Buy |
13,078
+2,089
| +19% | +$9.77K | ﹤0.01% | 1749 |
|
|
2019
Q3 | $58K | Buy |
10,989
+775
| +8% | +$4.13K | ﹤0.01% | 1592 |
|
|
2019
Q2 | $39K | Sell |
10,214
-273
| -3% | -$1.18K | ﹤0.01% | 1583 |
|
|
2019
Q1 | $53K | Buy |
10,487
+326
| +3% | +$958 | ﹤0.01% | 1612 |
|
|
2018
Q4 | $20K | Sell |
10,161
-1,640
| -14% | -$4.7K | ﹤0.01% | 1556 |
|
|
2018
Q3 | $45K | Sell |
11,801
-904
| -7% | -$2.83K | ﹤0.01% | 1729 |
|
|
2018
Q2 | $40K | Buy |
12,705
+1,521
| +14% | +$4.62K | ﹤0.01% | 1764 |
|
|
2018
Q1 | $27K | Buy |
11,184
+564
| +5% | +$1.87K | ﹤0.01% | 1701 |
|
|
2017
Q4 | $42K | Buy |
+10,620
| New | +$35.1K | ﹤0.01% | 1774 |
|
|
2016
Q1 | – | Sell |
-10,966
| Closed | -$27K | – | 1607 |
|
|
2015
Q4 | $27K | Buy |
+10,966
| New | +$31.4K | ﹤0.01% | 1698 |
|
Other funds holding CPRX
VCM
DM
VPM